The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer

SIMPLE SUMMARY: Breast cancer, especially in Asia, is on the rise. With improvements in tailored treatment, needs for more individualized subtyping are increasing. This retrospective study aimed to compare human epidermal growth factor receptor 2 (HER2)-low and HER2-0 breast cancers in hormone recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Woong Ki, Nam, Seok Jin, Kim, Seok Won, Lee, Jeong Eon, Yu, Jonghan, Ryu, Jai Min, Chae, Byung Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670388/
https://www.ncbi.nlm.nih.gov/pubmed/38001620
http://dx.doi.org/10.3390/cancers15225361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670388/
https://www.ncbi.nlm.nih.gov/pubmed/38001620
http://dx.doi.org/10.3390/cancers15225361

Ejemplares similares